Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 10 July 2025

 
 
 
   

News
 
Thumbnail

EFPIA Position on the Critical Medicines Act
04 July 2025

By embedding flexibility, coordination, and proportionate regulation into its implementation, the Act can support a... Read more
 
 
 
   

Blogs
 

Transforming regulatory pathways: A path to swift patient access (Guest Blog)
09 July 2025 - Katrin Rupalla

In today’s fast-paced world of medical advancement, regulatory frameworks have a crucial role to act as a key enabler... Read more
 
 
 
   

Events
 

Trials@Home Closing Event 2025
31 October 2025 (Utrecht, Hybrid)

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring... Read more

IHI Brokerage Event 2025
04 November 2025 (Brussels, Belgium)

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and... Read more
 
 
 
   

What are the trends in pharmaceutical R&D expenditure over time?

 
 
 
 
   

What we are reading
 
EU Health Coalition statement on the Life Sciences Strategy
On 07 July 2025 (EU Health Coalition)

The Strategy touches on several important areas for Europe’s life sciences ecosystem, including increased attention... Read more
IHI 2024 In Focus
On 03 July 2025 (IHI)

Every year, the Innovative Health Initiative compiles an annual report reflecting on the main achievements and milestones... Read more
The EU Biotech Mandate: A path to global leadership and resilience
On 03 July 2025 (EU Biotech and Life Sciences Alliance)

The 2024–2029 EU mandate will be critical to securing global leadership in biotechnology and life sciences in all... Read more
‘It’s now or never’ for Europe’s life sciences, EC and pharma insist
On 03 July 2025 (EU Perspectives)

On 2 July, the European Commission unveiled its Life Sciences Strategy. The three-phase plan aims to make Europe... Read more
The race to end HPV ‒ by vaccinating boys and girls
On 03 June 2025 (Vaccines Today)

Human papillomaviruses (HPV) cause an estimated 5% of cancers worldwide. Most people will come into contact with... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2025 All rights reserved Disclaimer